Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Journal of Cell Science
|
September 1, 1995
Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells
M M Atkinson, P D Lampe, H H Lin, et al.
Human Pathology
|
March 1, 1989
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin
M R Wick, T J Lillemoe, G T Copland, et al.
Minnesota Medicine
|
July 1, 1974
Multiple myeloma. Clinical evolution
D T Kiang, R D Sundberg, I E Fortuny, et al.
Medical and Pediatric Oncology
|
January 1, 1978
CCNU, vinblastine, and delalutin therapy in renal cell carcinoma
G J Vosika, M J Ryan, I A Fortuny, et al.
Cancer
|
February 1, 1995
Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group B
D T Kiang, B J Kennedy, J Younger, et al.
Human Pathology
|
October 1, 1992
Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry
T P Singleton, G A Niehans, F Gu, et al.
Journal of the National Cancer Institute
|
May 15, 1996
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B
S Tross, J Herndon, A Korzun, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Journal of Cell Science
|
September 1, 1995
Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells
M M Atkinson, P D Lampe, H H Lin, et al.
Human Pathology
|
March 1, 1989
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin
M R Wick, T J Lillemoe, G T Copland, et al.
Minnesota Medicine
|
July 1, 1974
Multiple myeloma. Clinical evolution
D T Kiang, R D Sundberg, I E Fortuny, et al.
Medical and Pediatric Oncology
|
January 1, 1978
CCNU, vinblastine, and delalutin therapy in renal cell carcinoma
G J Vosika, M J Ryan, I A Fortuny, et al.
Cancer
|
February 1, 1995
Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group B
D T Kiang, B J Kennedy, J Younger, et al.
Human Pathology
|
October 1, 1992
Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry
T P Singleton, G A Niehans, F Gu, et al.
Journal of the National Cancer Institute
|
May 15, 1996
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B
S Tross, J Herndon, A Korzun, et al.
Page
of 8